Skip to main content
. 2020 Aug 2;9(8):2481. doi: 10.3390/jcm9082481

Table 3.

Response to the treatment related to risk classification and cfBRAFV600E detection.

Risk Group # Cases BRAF Status # Cases Treatment Outcome
Excellent Response Indeterminate Response Biochemically Incomplete Structurally Incomplete
Low 19 mutant 4 1 1 2 0
wild-type 15 14 1 0 0
Intermediate 22 mutant 8 3 3 0 2
wild-type 14 8 4 0 2
High 16 mutant 12 2 0 4 6
wild-type 4 1 0 1 2